If selected, the location would house one of five centers at the heart of King County’s plans to expand the mental health system.

Express Scripts, Cigna, UnitedHealthcare, CVS Caremark and Optum Rx are among the payers that have added Yesintek to their ...

UnitedHealth Group CEO Andrew Witty will step down from his role at the top of the company due to personal reasons, the ...

There’s new leadership at the nation’s largest healthcare company, but the transition brings a familiar face back to the helm after a tumultuous year for UnitedHealth Group. Ten notes: 1. UnitedHealth ...

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) reported Q1 CY2025 results exceeding the market’s revenue ...

Biocon Biologics has secured multiple market access agreements for Yesintek (ustekinumab-kfce), its biosimilar to Stelara ...

Clinical studies showed that Yesintek is a biosimilar to Stelara and has similar pharmacokinetic, safety, efficacy and ...

Biocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 ...

Biocon Biologics secures market access for Yesintek in the US driven by demand from national and commercial formularies: Our Bureau, Bengaluru Monday, May 5, 2025, 12:15 Hrs [IST] ...

Biocon Biologics secures market access agreements for Yesintek, a biosimilar to Stelara, for treating autoimmune diseases in ...

Optum Rx results: Optum Rx increased the number ... for its group health business from the results for its individual commercial health insurance business. Total commercial enrollment increased ...